JBHT
56
7
PVH
52
-5
PNW
48
-2
WBA
24
-5
SYY
48
-2
GM
58
-5
CCL
67
13
INTU
74
4
EMR
48
4
RF
60
6
HON
53
-5
GE
68
7
PRGO
50
8
DAL
58
5
SHW
58
-3
ROK
70
20
ETN
69
-4
FRT
58
3
KHC
34
7
V
54
-2
JBHT
56
7
PVH
52
-5
PNW
48
-2
WBA
24
-5
SYY
48
-2
GM
58
-5
CCL
67
13
INTU
74
4
EMR
48
4
RF
60
6
HON
53
-5
GE
68
7
PRGO
50
8
DAL
58
5
SHW
58
-3
ROK
70
20
ETN
69
-4
FRT
58
3
KHC
34
7
V
54
-2
Financhill
Back

Akero Therapeutics Stock Predictions

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Sign up now to get this report and avoid a high-yield dividend trap - Yours FREE.
Buy
69

AKRO
Akero Therapeutics

Last Price:
22.40
Seasonality Move:
56.48%

7 Day Trial

ALL ACCESS PASS

$ 7

A Silent Invasion of America

Click here to see what you can do to make sure you're not left behind.

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 56.1% based on the past 4 years of stock performance.
  • Akero Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $23.16. The Score for AKRO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 56.1% based on the past 4 years of stock performance.

Akero Therapeutics Stock Rating

Buy
69
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • The current trend is moderately bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
53.77
52-Week Low:
11.25

Prediction Charts

Market Cap:
1.6B
Price in USD:
23.16
Volume:
672.36K
Beta:
-0.27

Technical Analysis

SMA50:
21.11
SMA100:
22.83
SMA200:
23.32
52-Wk Change:
-50.4%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 23.16 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-11 22.64 23.43 23.74 22.33
Jun-12 24.23 24.29 25.79 23.94
Jun-13 24.28 24.65 24.99 23.99
Jun-14 24.20 23.98 24.46 23.45
Jun-17 23.80 22.91 23.80 22.10
Jun-18 22.97 22.16 23.06 21.70
Jun-20 21.89 21.78 22.21 21.56
Jun-21 21.88 23.20 23.56 21.88
Jun-24 23.46 23.85 24.20 23.41
Jun-25 23.57 23.50 23.99 23.31
Jun-26 23.38 22.93 23.58 22.54
Jun-27 23.05 23.40 23.83 22.54
Jun-28 23.48 23.46 23.55 22.34
Jul-1 23.30 23.16 24.20 23.14

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.83 per share, and a decrease next year of $0.65 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.